CERT: רווח נקי למניה ב-12 החודשים האחרונים certara.com
Certara, Inc. (CERT) possesses transparent management and strong expertise in AI compliance. This 12-month net income per share chart demonstrates the issuer's commitment to operational stability, where the -0.05 metric determines the parameter status. Rising demand for biosimulations is expanding the client base, while the indispensable nature of the software for drug certification guarantees business resilience.
%20%D7%A8%D7%95%D7%95%D7%97%20%D7%9C%D7%9E%D7%A0%D7%99%D7%94%20%D7%91%D7%90%D7%A8%D7%91%D7%A2%D7%AA%20%D7%94%D7%A8%D7%91%D7%A2%D7%95%D7%A0%D7%99%D7%9D%20%D7%94%D7%90%D7%97%D7%A8%D7%95%D7%A0%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_CERT_-_Certara-Inc._-_Earnings-per-share-for-the-last-four-quarters "Certara Corp - רווח נקי למניה (EPS TTM) CERT (תקופה 04.07.2022 - 12.11.2026) | 👁️GURU.Markets👁️")
פילוחי נתונים אנליטיים מרוכזים עבור Certara Inc (CERT)
The annual net income per share trend for Certara, Inc. (CERT) reflects the business's actual profitability by dividing the total financial result over four quarters by the number of outstanding securities. This indicator enables an assessment of the monetization efficiency of its proprietary biosimulation software and the resilience of earnings under strict FDA regulation, separating fundamental growth from market speculation.
